These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 17251496

  • 1. Retinal dysfunction in diabetic ren-2 rats is ameliorated by treatment with valsartan but not atenolol.
    Phipps JA, Wilkinson-Berka JL, Fletcher EL.
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):927-34. PubMed ID: 17251496
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Angiotensin receptor blocker added to previous antihypertensive agents on arteries of diabetic hypertensive patients.
    Savoia C, Touyz RM, Endemann DH, Pu Q, Ko EA, De Ciuceis C, Schiffrin EL.
    Hypertension; 2006 Aug; 48(2):271-7. PubMed ID: 16785331
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The vasoneuronal effects of AT1 receptor blockade in a rat model of retinopathy of prematurity.
    Hatzopoulos KM, Vessey KA, Wilkinson-Berka JL, Fletcher EL.
    Invest Ophthalmol Vis Sci; 2014 Jun 03; 55(6):3957-70. PubMed ID: 24894399
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Paired-flash identification of rod and cone dysfunction in the diabetic rat.
    Phipps JA, Fletcher EL, Vingrys AJ.
    Invest Ophthalmol Vis Sci; 2004 Dec 03; 45(12):4592-600. PubMed ID: 15557472
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Hemodynamic and metabolic responses to valsartan and atenolol in obese hypertensive patients.
    Jordan J, Engeli S, Boschmann M, Weidinger G, Luft FC, Sharma AM, Kreuzberg U.
    J Hypertens; 2005 Dec 03; 23(12):2313-8. PubMed ID: 16269974
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of simvastatin given alone and in combination with valsartan or enalapril on blood pressure and the structure of mesenteric resistance arteries and the basilar artery in the genetically hypertensive rat model.
    Ledingham JM, Laverty R.
    Clin Exp Pharmacol Physiol; 2005 Dec 03; 32(1-2):76-85. PubMed ID: 15730439
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.
    Nagai N, Izumi-Nagai K, Oike Y, Koto T, Satofuka S, Ozawa Y, Yamashiro K, Inoue M, Tsubota K, Umezawa K, Ishida S.
    Invest Ophthalmol Vis Sci; 2007 Sep 03; 48(9):4342-50. PubMed ID: 17724226
    [Abstract] [Full Text] [Related]

  • 18. Anti-inflammatory effects of AT1 receptor blockade provide end-organ protection in stroke-prone rats independently from blood pressure fall.
    Sironi L, Gelosa P, Guerrini U, Banfi C, Crippa V, Brioschi M, Gianazza E, Nobili E, Gianella A, de Gasparo M, Tremoli E.
    J Pharmacol Exp Ther; 2004 Dec 03; 311(3):989-95. PubMed ID: 15302895
    [Abstract] [Full Text] [Related]

  • 19. Effect of intensive blood pressure control with valsartan on urinary albumin excretion in normotensive patients with type 2 diabetes.
    Estacio RO, Coll JR, Tran ZV, Schrier RW.
    Am J Hypertens; 2006 Dec 03; 19(12):1241-8. PubMed ID: 17161769
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.